Inflammation and caspase activation in long-term renal ischemia/reperfusion injury and immunosuppression in rats

Kidney International

Volumn 68, Issue 5, 2005, Pages 2050-2067

  Yang, Bin ^a   Jain, Sunjay ^b   Pawluczyk, Izabella Z A ^b   Imtiaz, Shehla ^b   Bowley, Lee ^b   Ashra, Shairbanu Y ^b   Nicholson, Michael L ^b  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

IL 1 expression and caspase 1 and caspase 3 activation; Immunosuppressants; Interstitial inflammation; Long term renal ischemia reperfusion injury

Indexed keywords

CASPASE; CASPASE 3; CREATINE; CYCLOSPORIN A; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN SUBUNIT; RAPAMYCIN; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; INTERSTITIUM; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE; MACROPHAGE; MALE; MOLECULAR WEIGHT; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; REPERFUSION INJURY; STAINING; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CASPASE 1; CASPASE 3; CASPASES; CHRONIC DISEASE; CYCLOSPORINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXTRACELLULAR MATRIX; FIBROSIS; GLOMERULONEPHRITIS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-1; MALE; MYCOPHENOLIC ACID; RATS; RATS, WISTAR; REPERFUSION INJURY; SIROLIMUS; TACROLIMUS;

EID: 30944469853     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00662.x     Document Type: Conference Paper

References (66)

1. RACUSEN LC, SOLEZ K, COLVIN RB, et al: The Banff 97 working classification of renal allograft pathology. Kidney Int 55:713-723, 1999
2. JONES EA, SHOSKES DA: The effect of mycophenolate mofetil and polyphenolic bioflavonoids on renal ischemia reperfusion injury and repair. J Urol 163:999-1004, 2000
3. NICHOLSON ML, METCALFE MS, WHITE SA, et al: A comparison of the results of renal transplantation from non-heart-beating, conventional cadaveric, and living donors. Kidney Int 58:2585-2591, 2000
4. DAEMEN MA, DE VRIES B, BUURMAN WA: Apoptosis and inflammation in renal reperfusion injury. Transplantation 73:1693-1700, 2002
5. BURNE-TANEY MJ, KOflER J, YOKOTA N, et al: Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Am J Physiol Renal Physiol 285:F87-F94, 2003
6. SHOSKES DA, PARFREY NA, HALLORAN PF: Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 49:201-207, 1990
7. WINN RK, RAMAMOORTHY C, VEDDER NB, et al: Leukocyte-endothelial cell interactions in ischemia-reperfusion injury. Ann NY Acad Sci 832:311-321, 1997
8. DE GREEF KE, YSEBAERT DK, GHIELLI M, et al: Neutrophils and acute ischemia-reperfusion injury. J Nephrol 11:110-122, 1998
9. MCCORD JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312:159-163, 1985
10. SINGBARTL K, GREEN SA, LEY K: Blocking P-selectin protects from ischemia/reperfusion-induced acute renal failure. FASEB J 14:48-54, 2000
11. DRAGUN D, TULLIUS SG, PARK JK, et al: ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation. Kidney Int 54:590-602, 1998
12. ZHOU W, FARRAR CA, ABE K, et al: Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 105:1363-1371, 2000
13. DE VRIES B, MATTHIJSEN RA, WOLFS TG, et al: Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: Inhibition of late apoptosis and inflammation. Transplantation 75:375-382, 2003
14. HOWARD AD, KOSTURA MJ, THORNBERRY N, et al: IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha. J Immunol 147:2964-2969, 1991
15. THORNBERRY NA, BULL HG, CALAYCAY JR, et al: A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356:768-774, 1992
16. HAQ M, NORMAN J, SABA SR, et al: Role of IL-1 in renal ischemic reperfusion injury. J Am Soc Nephrol 9:614-619, 1998
17. CREAGH EM, CONROY H, MARTIN SJ: Caspase-activation pathways in apoptosis and immunity. Immunol Rev 193:10-21, 2003
18. MELNIKOV VY, ECDER T, FANTUZZI G, et al: Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest 107:1145-1152, 2001
19. MIWA K, ASANO M, HORAI R, et al: Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med 4:1287-1292, 1998
20. PIRHONEN J, SARENEVA T, JULKUNEN I, MATIKAINEN S: Virus infection induces proteolytic processing of IL-18 in human macrophages via caspase-1 and caspase-3 activation. Eur J Immunol 31:726-733, 2001
21. FAOUZI S, BURCKHARDT BE, HANSON JC, et al: Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway. J Biol Chem 276:49077-49082, 2001
22. BEHRENSDORF HA, VAN DE CRAEN M, KNIES UE, et al: The endothelial monocyte-activating polypeptide II (EMAP II) is a substrate for caspase-7. FEBS Lett 466:143-147, 2000
23. HUR J, KIM SY, KIM H, et al: Induction of caspase-11 by inflammatory stimuli in rat astrocytes: Lipopolysaccharide induction through p38 mitogen-activated protein kinase pathway. FEBS Lett 507:157-162, 2001
24. HAUG CE, COLVIN RB, DELMONICO FL, et al: A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 55:766-772 [discussion 772-763], 1993
25. DAEMEN MA, VAN DE VEN MW, HEINEMAN E, BUURMAN WA: Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia-reperfusion injury. Transplantation 67:792-800, 1999
26. DAEMEN MA, VAN'T VEER C, WOLFS TG, BUURMAN WA: Ischemia/reperfusion- induced IFN-gamma up-regulation: Involvement of IL-12 and IL-18. J Immunol 162:5506-5510, 1999
27. DE VRIES B, MATTHIJSEN RA, VAN BIJNEN AA, et al: Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation. Am J Pathol 163:47-56, 2003
28. KLAUSNER JM, PATERSON IS, GOLDMAN G, et al: Postischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol 256:F794-F802, 1989
29. DAEMEN MA, VAN'T VEER C, DENECKER G, et al: Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 104:541-549, 1999
30. JAIN S, BICKNELL GR, NICHOLSON ML: Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury. Br J Surg 87:1563-1568, 2000
31. JAIN S, BICKNELL GR, WHITING PH, NICHOLSON ML: Rapamycin reduces expression of fibrosis-associated genes in an experimental model of renal ischaemia reperfusion injury. Transplant Proc 33:556-558, 2001
32. JAIN S, BICKNELL GR, NICHOLSON ML: Molecular changes in extracellular matrix turnover after renal ischaemia-reperfusion injury. Br J Surg 87:1188-1192, 2000
33. WEIGHT SC, FURNESS PN, NICHOLSON ML: New model of renal warm ischaemia-reperfusion injury for comparative functional, morphological and pathophysiological studies. Br J Surg 85:1669-1673, 1998
34. YSEBAERT DK, DE GREEF KE, VERCAUTEREN SR, et al: Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury. Kidney Int 64:864-873, 2003
35. SUN DF, FUJIGAKI Y, FUJIMOTO T, et al: Mycophenolate mofetil inhibits regenerative repair in uranyl acetate-induced acute renal failure by reduced interstitial cellular response. Am J Pathol 161:217-227, 2002
36. LIEBERTHAL W, FUHRO R, ANDRY CC, et al: Rapamycin impairs recovery from acute renal failure: Role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 281:F693-F706, 2001
37. WALLER JR, MURPHY GJ, BICKNELL GR, et al: Effects of the combination of rapamycin with tacrolimus or cyclosporin on experimental intimal hyperplasia. Br J Surg 89:1390-1395, 2002
38. GRIMM PC, NICKERSON P, GOUGH J, et al: Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. J Am Soc Nephrol 14:1662-1668, 2003
39. SAUNDERS RN, BICKNELL GR, NICHOLSON ML: The impact of cyclosporine dose reduction with or without the addition of rapamycin on functional, molecular, and histological markers of chronic allograft nephropathy. Transplantation 75:772-780, 2003
40. THOMAS GL, YANG B, WAGNER BE, et al: Cellular apoptosis and proliferation in experimental renal fibrosis. Nephrol Dial Transplant 13:2216-2226, 1998
41. YANG B, JOHNSON TS, THOMAS GL, et al: Apoptosis and caspase-3 in experimental anti-glomerular basement membrane nephritis. J Am Soc Nephrol 12:485-495, 2001
42. LIAO J, XU X, WARGOVICH MJ: Direct reprobing with anti-beta-actin antibody as an internal control for western blotting analysis. Biotechniques 28:216-218, 2000
43. YANG B, EL NAHAS AM, THOMAS GL, et al: Caspase-3 and apoptosis in experimental chronic renal scarring. Kidney Int 60:1765-1776, 2001
44. YANG B, JOHNSON TS, HAYLOR JL, et al: Effects of caspase inhibition on the progression of experimental glomerulonephritis. Kidney Int 63:2050-2064, 2003
45. ANDERSEN P, HERON I: Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures. J Immunol Methods 161:29-39, 1993
46. NICHOLSON DW, ALI A, THORNBERRY NA, et al: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43, 1995
47. SALVESEN GS, DIXIT VM: Caspases: Intracellular signaling by proteolysis. Cell 91:443-446, 1997
48. KUIDA K, LIPPKE JA, KU G, et al: Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267:2000-2003, 1995
49. SCHIELKE GP, YANG GY, SHIVERS BD, BETZ AL: Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J Cereb Blood Flow Metab 18:180-185, 1998
50. DAEMEN MA, DENECKER G, VAN'T VEER C, et al: Activated caspase-1 is not a central mediator of inflammation in the course of ischemia-reperfusion. Transplantation 71:778-784, 2001
51. SCHLEGEL J, PETERS I, ORRENIUS S, et al: CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis. J Biol Chem 271:1841-1844, 1996
52. FERNANDES-ALNEMRI T, LITWACK G, ALNEMRI ES: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 269:30761-30764, 1994
53. SABBATINI P, HAN J, CHIOU SK, et al: Interleukin 1 beta converting enzyme-like proteases are essential for p53-mediated transcriptionally dependent apoptosis. Cell Growth Differ 8:643-653, 1997
54. CHIEN CT, LEE PH, CHEN CF, et al: De novo demonstration and co-localization of free-radical production and apoptosis formation in rat kidney subjected to ischemia/reperfusion. J Am Soc Nephrol 12:973-982, 2001
55. KAUSHAL GP, SINGH AB, SHAH SV: Identification of gene family of caspases in rat kidney and altered expression in ischemia-reperfusion injury. Am J Physiol 274: F587-F595, 1998
56. ARMSTRONG RC, AJA TJ, HOANG KD, et al: Activation of the CED3/ICE-related protease CPP32 in cerebellar granule neurons undergoing apoptosis but not necrosis. J Neurosci 15:553-562, 1997
57. SHARPLES EJ, PATEL N, BROWN P, et al: Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 15:2115-2124, 2004
58. LEE JH, JUNG KJ, KIM JW, et al: Suppression of apoptosis by calorie restriction in aged kidney. Exp Gerontol 39:1361-1368, 2004
59. SOLA A, ALFARO V, VINAS JL, HOTTER G: Exogenous adenosine enhances caspase-3 activity in warm renal ischaemia. Pflugers Arch 447:387-391, 2004
60. YANG B, EL NAHAS AM, FISHER M, et al: Inhibitors directed towards caspase-1 and -3 are less effective than pan caspase inhibition in preventing renal proximal tubular cell apoptosis. Nephron Exp Nephrol 96:e39-e51, 2004
61. Li C, YANG CW, KIM WY, et al: Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine. Am J Physiol Renal Physiol 284:F389-F398, 2003
62. STACCHIOTTI A, LAVAZZA A, REZZANI R, et al: Cyclosporine A-induced kidney alterations are limited by melatonin in rats: An electron microscope study. Ultrastruct Pathol 26:81-87, 2002
63. MANSOUR M, DABA MH, GADO A, et al: Protective effect of L-arginine against nephrotoxicity induced by cyclosporine in normal rats. Pharmacol Res 45:441-446, 2002
64. SHI Y, MELNIKOV VY, SCHRIER RW, EDELSTEIN CL: Downregulation of the calpain inhibitor protein calpastatin by caspases during renal ischemia-reperfusion. Am J Physiol Renal Physiol 279:F509-F517, 2000
65. KOHLI V, GAO W, CAMARGO CA, JR., CLAVIEN PA: Calpain is a mediator of preservation-reperfusion injury in rat liver transplantation. Proc Natl Acad Sci USA 94:9354-9359, 1997
66. CHATTERJEE PK, BROWN PA, CUZZOCREA S, et al: Calpain inhibitor-1 reduces renal ischemia/reperfusion injury in the rat. Kidney Int 59:2073-2083, 2001